ORKA · Insider Trading
Oruka Therapeutics, Inc. Common Stock
Every open-market purchase and sale reported by ORKA officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-20 | Paul T Quinlan | General Counsel | MIXED | — | −$636.53K |
| 2026-10-15 | Joana Goncalves | Chief Medical Officer | MIXED | — | −$472.41K |
| 2026-10-13 | Arjun Agarwal | Senior Vice President, Finance | MIXED | — | −$648.99K |
| 2026-10-02 | Lawrence Otto Klein | Chief Executive Officer | MIXED | — | −$1.90M |
| 2026-09-21 | Arjun Agarwal | Senior Vice President, Finance | Sell | −533 | −$51.03K |
| 2026-09-21 | Paul T Quinlan | General Counsel | MIXED | — | −$858.42K |
| 2026-09-15 | Lawrence Otto Klein | Chief Executive Officer | Sell | −2,452 | −$234.68K |
| 2026-09-15 | Laura Lee Sandler | Chief Operating Officer | Sell | −906 | −$86.71K |
| 2026-09-15 | Paul T Quinlan | General Counsel | Sell | −1,039 | −$99.44K |
| 2026-09-15 | Joana Goncalves | Chief Medical Officer | MIXED | −947 | −$682.90K |
| 2026-09-15 | Arjun Agarwal | Senior Vice President, Finance | MIXED | −560 | −$775.84K |
| 2026-09-01 | Laura Lee Sandler | Chief Operating Officer | MIXED | — | −$420.10K |
| 2026-09-01 | Lawrence Otto Klein | Chief Executive Officer | MIXED | — | −$6.30M |
| 2026-08-25 | Larry Todd Edwards | Chief Commercial Officer | A | +100,000 | — |
| 2026-08-17 | Joana Goncalves | Chief Medical Officer | MIXED | — | −$731.64K |
| 2026-08-14 | Arjun Agarwal | Senior Vice President, Finance | MIXED | — | −$909.66K |
| 2026-08-14 | Paul T Quinlan | General Counsel | MIXED | — | −$5.04M |
| 2026-07-15 | Joana Goncalves | Chief Medical Officer | MIXED | — | −$552.70K |
| 2026-07-13 | Arjun Agarwal | Senior Vice President, Finance | MIXED | — | −$689.28K |
| 2026-07-01 | Laura Lee Sandler | Chief Operating Officer | MIXED | — | −$433.08K |
| 2026-07-01 | Peter Evan Harwin | Director | MIXED | — | −$1.50B |
| 2026-06-22 | Arjun Agarwal | Senior Vice President, Finance | Sell | −1,587 | −$128.47K |
| 2026-06-15 | Lawrence Otto Klein | Chief Executive Officer | Sell | −1,729 | −$120.49K |
| 2026-06-15 | Laura Lee Sandler | Chief Operating Officer | Sell | −600 | −$41.81K |
| 2026-06-15 | Arjun Agarwal | Senior Vice President, Finance | MIXED | −395 | −$536.86K |
| 2026-06-15 | Paul T Quinlan | General Counsel | Sell | −733 | −$51.08K |
| 2026-06-15 | Joana Goncalves | Chief Medical Officer | MIXED | −947 | −$499.37K |
| 2026-06-12 | Carl Dambkowski | Director | Sell | −35,000 | −$2.45M |
| 2026-06-03 | Kristine M Ball | Director | A | +9,136 deriv. | — |
| 2026-06-03 | Christopher Nathan Martin | Director | A | +9,136 deriv. | — |
| 2026-06-03 | Carl Dambkowski | Director | A | +9,136 deriv. | — |
| 2026-06-03 | Fairmount Healthcare Fund II L.P. | Director | A | +45,680 deriv. | — |
| 2026-06-03 | Samarth Kulkarni | Director | A | +9,136 deriv. | — |
| 2026-05-22 | Carl Dambkowski | Director | MIXED | −42,740 | −$5.70M |
| 2026-05-18 | Arjun Agarwal | Senior Vice President, Finance | MIXED | −2,457 | −$382.21K |
| 2026-05-15 | Joana Goncalves | Chief Medical Officer | MIXED | — | −$381.70K |
| 2026-05-01 | Laura Lee Sandler | Chief Operating Officer | MIXED | — | −$280.38K |
| 2026-04-15 | Joana Goncalves | Chief Medical Officer | MIXED | — | −$411.59K |
| 2026-03-17 | Lawrence Otto Klein | Chief Executive Officer | Sell | −1,729 | −$71.41K |
| 2026-03-17 | Paul T Quinlan | General Counsel | Sell | −733 | −$30.27K |
| 2026-03-17 | Laura Lee Sandler | Chief Operating Officer | Sell | −600 | −$24.78K |
| 2026-03-17 | Arjun Agarwal | Senior Vice President, Finance | Sell | −395 | −$16.31K |
| 2026-03-17 | Joana Goncalves | Chief Medical Officer | MIXED | −641 | −$261.32K |
| 2026-03-02 | Laura Lee Sandler | Chief Operating Officer | MIXED | — | −$128.82K |
| 2026-02-17 | Joana Goncalves | Chief Medical Officer | MIXED | — | −$175.32K |
| 2026-01-23 | Laura Lee Sandler | Chief Operating Officer | A | +32,500 | — |
| 2026-01-23 | Carl Dambkowski | Director | J | +116,483 | — |
| 2026-01-23 | Joana Goncalves | Chief Medical Officer | A | +32,500 | — |
| 2026-01-23 | Arjun Agarwal | SVP, Finance | A | +17,500 | — |
| 2026-01-23 | Paul T Quinlan | General Counsel | A | +32,500 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| VHCP Management EG, LLC | 10%+ Owner | 4,044,684 | $365.36M |
| Tomas Kiselak | Director | 2,573,308 | $232.45M |
| Peter Evan Harwin | Director | 1,131,954 | $102.25M |
| Lawrence Otto Klein | Chief Executive Officer | 923,328 | $83.40M |
| Fairmount Healthcare Fund II L.P. | Director | 638,614 | $57.69M |
| Laura Lee Sandler | Chief Operating Officer | 235,478 | $21.27M |
| Larry Todd Edwards | Chief Commercial Officer | 100,000 | $9.03M |
| Carl Dambkowski | Director | 51,326 | $4.64M |
| Paul T Quinlan | General Counsel | 37,095 | $3.35M |
| Joana Goncalves | Chief Medical Officer | 32,671 | $2.95M |
| Arjun Agarwal | Senior Vice President, Finance | 14,219 | $1.28M |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ORKA quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.